2020
DOI: 10.1007/978-3-030-30182-8_21
|View full text |Cite
|
Sign up to set email alerts
|

Bioactive Compounds of Camu-Camu (Myrciaria dubia (Kunth) McVaugh)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 85 publications
0
1
0
Order By: Relevance
“…Specific biological activities of the fruit associated with the prevention of metabolic syndrome diseases include antihypertensive and antihyperglycemic activities by the inhibition of angiotensin-converting enzyme-I (ACE-I) and α-amylase and α-glucosidase enzymes (responsible for the hydrolysis of polysaccharides in the human intestine) have been respectively reported (Fidelis et al, 2018;García-Chacón et al, 2022). In fact, as part of traditional medicine, Amazonian indigenous communities consumed camu-camu fruit for the treatment of some diseases such as diabetes, influenza, hypercholester-olemia, inflammation, migraine, and cancer, in addition to using the fruit as a phytomedicine to counter secondary effects from cardiovascular diseases (CVDs) (Castro et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…Specific biological activities of the fruit associated with the prevention of metabolic syndrome diseases include antihypertensive and antihyperglycemic activities by the inhibition of angiotensin-converting enzyme-I (ACE-I) and α-amylase and α-glucosidase enzymes (responsible for the hydrolysis of polysaccharides in the human intestine) have been respectively reported (Fidelis et al, 2018;García-Chacón et al, 2022). In fact, as part of traditional medicine, Amazonian indigenous communities consumed camu-camu fruit for the treatment of some diseases such as diabetes, influenza, hypercholester-olemia, inflammation, migraine, and cancer, in addition to using the fruit as a phytomedicine to counter secondary effects from cardiovascular diseases (CVDs) (Castro et al, 2020).…”
Section: Introductionmentioning
confidence: 99%